Detalhe da pesquisa
1.
Relevance of the combination of external beam radiotherapy with the hypoxia-activated prodrug ICF05016 in an experimental model of extraskeletal myxoid chondrosarcoma.
Invest New Drugs
; 39(2): 295-303, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32948981
2.
Design, synthesis and evaluation of targeted hypoxia-activated prodrugs applied to chondrosarcoma chemotherapy.
Bioorg Chem
; 98: 103747, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32208207
3.
The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers.
Sci Transl Med
; 16(731): eadd1834, 2024 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38266104
4.
Isolation and Identification of Dendritic Cell Subsets from Human and Mouse Tumors.
Methods Mol Biol
; 2618: 187-197, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36905518
5.
Multicellular tumor spheroids of LNCaP-Luc prostate cancer cells as in vitro screening models for cytotoxic drugs.
Am J Cancer Res
; 12(3): 1116-1128, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35411223
6.
Structure-activity relationship study of hypoxia-activated prodrugs for proteoglycan-targeted chemotherapy in chondrosarcoma.
Eur J Med Chem
; 158: 51-67, 2018 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30199705
7.
Development and characterization of a human three-dimensional chondrosarcoma culture for in vitro drug testing.
PLoS One
; 12(7): e0181340, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28704566
8.
Proteoglycan-targeting applied to hypoxia-activated prodrug therapy in chondrosarcoma: first proof-of-concept.
Oncotarget
; 8(56): 95824-95840, 2017 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29221170
9.
Proteoglycans as Target for an Innovative Therapeutic Approach in Chondrosarcoma: Preclinical Proof of Concept.
Mol Cancer Ther
; 15(11): 2575-2585, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27573424